Comparison of Cefepime versus Ceftriaxone-Amikacin as Empirical Regimens for the Treatment of Febrile Neutropenia in Acute Leukemia Patients

Publisher： Karger

E-ISSN： 1421-9794|47|5|381-384

ISSN： 0009-3157

Source： Chemotherapy, Vol.47, Iss.5, 2001-09, pp. : 381-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Febrile Neutropenia with Cefepime Monotherapy

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia

By  

Chemotherapy, Vol. 44, Iss. 5, 1998-08 ,pp. : 343-354

Karger

Access to resources Recommend Favorite

Ceftriaxone for the Treatment of Febrile Episodes in Nonneutropenic Patients with Hematooncological Disease or HIV Infection: Comparison of Outpatient and Inpatient Care

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Ceftriaxone plus Once Daily Aminoglycoside with Filgrastim for Treatment of Febrile Neutropenia: Early Hospital Discharge vs. Standard In-Patient Care

By  

Chemotherapy, Vol. 45, Iss. 6, 1999-11 ,pp. : 466-476

Karger

Access to resources Recommend Favorite

A Comparative Study of Cefepime versus Ceftazidime as Empiric Therapy of Febrile Episodes in Neutropenic Patients

By  

Chemotherapy, Vol. 45, Iss. 5, 1999-08 ,pp. : 370-379

Karger

Access to resources Recommend Favorite